These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2505290)

  • 1. Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat.
    Whishaw IQ; Auer RN
    Psychopharmacology (Berl); 1989; 98(4):500-7. PubMed ID: 2505290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic receptor blockade in the rat impairs locale but not taxon strategies for place navigation in a swimming pool.
    Whishaw IQ
    Behav Neurosci; 1985 Oct; 99(5):979-1005. PubMed ID: 3843314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The topography of MK-801-induced locomotor patterns in rats.
    Ford LM; Norman AB; Sanberg PR
    Physiol Behav; 1989 Oct; 46(4):755-8. PubMed ID: 2557649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of structural ischemic brain damage to neurobehavioural deficit: the effect of postischemic MK-801.
    Rod MR; Whishaw IQ; Auer RN
    Can J Psychol; 1990 Jun; 44(2):196-209. PubMed ID: 2200595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio).
    Swain HA; Sigstad C; Scalzo FM
    Neurotoxicol Teratol; 2004; 26(6):725-9. PubMed ID: 15451036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
    Marquis KL; Paquette NC; Gussio RP; Moreton JE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
    Kulkarni SK; Ticku MK
    Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat.
    Sutherland RJ; Whishaw IQ; Regehr JC
    J Comp Physiol Psychol; 1982 Aug; 96(4):563-73. PubMed ID: 7119176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M; Cho AK; Nabeshima T
    Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: evidence from sensory, motor, and acquisition tests in a swimming pool.
    Whishaw IQ; Tomie JA
    Behav Neurosci; 1987 Oct; 101(5):603-16. PubMed ID: 3675838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The noncompetitive N-methyl-D-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits.
    Scheller MS; Zornow MH; Fleischer JE; Shearman GT; Greber TF
    Neuropharmacology; 1989 Jul; 28(7):677-81. PubMed ID: 2548110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task.
    Butelman ER
    Pharmacol Biochem Behav; 1989 Sep; 34(1):13-6. PubMed ID: 2696982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
    Stuchlík A; Vales K
    Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
    Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ
    Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze.
    Heale V; Harley C
    Pharmacol Biochem Behav; 1990 May; 36(1):145-9. PubMed ID: 1971949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of MK-801 in the rat.
    Wozniak DF; Olney JW; Kettinger L; Price M; Miller JP
    Psychopharmacology (Berl); 1990; 101(1):47-56. PubMed ID: 2188277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnesic effect of the novel anticonvulsant MK-801.
    Benvenga MJ; Spaulding TC
    Pharmacol Biochem Behav; 1988 May; 30(1):205-7. PubMed ID: 3051045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks.
    Pitkänen M; Sirviö J; MacDonald E; Niemi S; Ekonsalo T; Riekkinen P
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):457-63. PubMed ID: 8998397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.